CIBERDEM, Vall dHebron Research Institute, Barcelona, Spain, 2 Ophthalmology Research Group, Vall dHebron Research Institute, Barcelona, Spain
Changes in microbial composition, such as a decrease in Firmicutes and an increase in Bacteroidota, have been closely associated with dysregulated fat metabolism 40,41,42
Funding new research to support adjunctive therapies The lack of support and funding from the FDA and diabetes companies for adjunctive therapies is discouraging for many, which is why organizations like Breakthrough T1D play a key role in supporting innovative studies
Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA-approved for weight management in adults with obesity or overweight with a weight-related health condition, regardless of whether diabetes is present
Week 10 of a GHK-Cu protocol often looks so much better than week 1 that the difference is remarkable, but memory is not an accurate baseline